AMEX · Financial Statements
Impact BioMedical, Inc. (IBO) Financial Statements
$4.47
AMEX: IBO
Market Cap $38.15M
Overview Financials Dividend Impact BioMedical, Inc. most recently reported annual revenue of $0, net profit of $-12.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-3.0M $-4.0M $-29.0M $-4.0M Net Profit $-7.0M $-7.0M $-4.0M $-25.0M $-12.0M EPS $-7.70 $-7.70 $-0.88 $-0.09 $-4.80 Op Margin -6808.0% -6808.0% — — -13343.8%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $56.0M $46.0M $45.0M $20.0M $17.0M Total Liabilities $17.0M $14.0M $16.0M $13.0M $2.0M Cash $0 $0 $0 $2.0M $0 Borrowings $13.0M $10.0M $12.0M $9.0M $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-2.0M $-3.0M $-6.0M $-2.0M Investing Cash Flow $-1.0M $-1.0M $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $3.0M $-2.0M Free Cash Flow $-3.0M $-3.0M $-3.0M $-6.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA -117.58 FCF Yield -1.08% Quick Ratio 0.13 Interest Coverage -19.45 Return 1Y -31.34% Return 3Y — Return 5Y —
Screens featuring this stock